204 related articles for article (PubMed ID: 19171469)
1. Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment.
Baldassarre D; Porta B; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Veglia F; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):481-90. PubMed ID: 19171469
[TBL] [Abstract][Full Text] [Related]
2. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.
Forst T; Wilhelm B; Pfützner A; Fuchs W; Lehmann U; Schaper F; Weber M; Müller J; Konrad T; Hanefeld M
Diab Vasc Dis Res; 2008 Nov; 5(4):298-303. PubMed ID: 18958840
[TBL] [Abstract][Full Text] [Related]
4. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease.
Yu CM; Zhang Q; Lam L; Lin H; Kong SL; Chan W; Fung JW; Cheng KK; Chan IH; Lee SW; Sanderson JE; Lam CW
Heart; 2007 Aug; 93(8):933-9. PubMed ID: 17344325
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Liu M; Wang F; Wang Y; Jin R
Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
Alber HF; Frick M; Süssenbacher A; Dörler J; Dichtl W; Stocker EM; Pachinger O; Weidinger F
Wien Med Wochenschr; 2007 Feb; 157(3-4):73-8. PubMed ID: 17340064
[TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering with atorvastatin improves tissue characteristics of carotid plaque.
Katakami N; Sakamoto K; Kaneto H; Matsuhisa M; Hori M; Yamasaki Y; Kosugi K; Waki H
Atherosclerosis; 2005 Dec; 183(2):369-71. PubMed ID: 16162349
[No Abstract] [Full Text] [Related]
9. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
[TBL] [Abstract][Full Text] [Related]
10. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
[TBL] [Abstract][Full Text] [Related]
11. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
[TBL] [Abstract][Full Text] [Related]
12. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
Li Q; Deng SB; Xia S; Du JL; She Q
Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
[TBL] [Abstract][Full Text] [Related]
13. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.
Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R
Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
[TBL] [Abstract][Full Text] [Related]
15. Re-elevation of high-sensitivity C-reactive protein but not the von Willebrand Factor after withdrawing atorvastatin therapy in patients with unstable angina undergoing coronary artery stenting.
Yip HK; Youssef AA; Chua S; Hung WC; Chen YH; Yeh KH; Wu CJ; Hang CL
Int Heart J; 2006 Jul; 47(4):501-9. PubMed ID: 16960405
[TBL] [Abstract][Full Text] [Related]
16. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia.
Guardamagna O; Abello F; Saracco P; Baracco V; Rolfo E; Pirro M
Atherosclerosis; 2009 Dec; 207(2):471-5. PubMed ID: 19560772
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
[TBL] [Abstract][Full Text] [Related]
18. Lupus Atherosclerosis Prevention Study (LAPS).
Petri MA; Kiani AN; Post W; Christopher-Stine L; Magder LS
Ann Rheum Dis; 2011 May; 70(5):760-5. PubMed ID: 21177297
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease.
Seljeflot I; Tonstad S; Hjermann I; Arnesen H
Atherosclerosis; 2002 May; 162(1):179-85. PubMed ID: 11947912
[TBL] [Abstract][Full Text] [Related]
20. Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.
Hognestad A; Aukrust P; Wergeland R; Stokke O; Gullestad L; Semb AG; Holm T; Andreassen AK; Kjekshus JK
Clin Cardiol; 2004 Apr; 27(4):199-203. PubMed ID: 15119693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
